These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2338196)

  • 21. Relapse of acute B viral hepatitis--role of delta agent.
    Govindarajan S; Valinluck B; Peters L
    Gut; 1986 Jan; 27(1):19-22. PubMed ID: 3949233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Short communication: evaluation of the correlation between hepatitis D virus (HDV) RNA positivity and HDV antibodies].
    Ozekinci T; Atmaca S; Akpolat N; Temiz H; Arikan E
    Mikrobiyol Bul; 2005 Jul; 39(3):345-9. PubMed ID: 16358495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological markers for delta hepatitis.
    Buti M; Esteban R; Jardi R; Esteban JI; Guardia J
    Lancet; 1987 Apr; 1(8536):815. PubMed ID: 2882229
    [No Abstract]   [Full Text] [Related]  

  • 24. [Investigation of anticardiolipin antibodies in chronic hepatitis B infection together with total anti-delta positivity].
    Meşe S; Ozekinci T; Atmaca S; Arikan E; Akin D
    Mikrobiyol Bul; 2008 Jul; 42(3):483-7. PubMed ID: 18822893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis delta infection in north-west Spain.
    Castro A; Pedreira J; Sánchez P
    Lancet; 1989 Mar; 1(8639):665. PubMed ID: 2564473
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum alanine aminotransferase levels and prevalence of hepatitis A, B, and delta in outpatients.
    Jensen DM; Dickerson DD; Linderman MA; Kessler H
    Arch Intern Med; 1987 Oct; 147(10):1734-7. PubMed ID: 2821943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Delta agent infection and immunoglobulin G in acute HBsAg-positive hepatitis with chronic course].
    Tagariello G; Pasquinucci S; Belussi F; Dal Canton A; Alberti A
    Boll Ist Sieroter Milan; 1987; 66(6):485-8. PubMed ID: 3453151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differential diagnosis of hepatitis A, B, C, D and E. Clinical, biochemical and virus serologic criteria. 4: Hepatitis D serology].
    Eisenburg J
    Fortschr Med; 1995 Jan; 113(3):35-6. PubMed ID: 7890271
    [No Abstract]   [Full Text] [Related]  

  • 29. Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India.
    Saravanan S; Velu V; Kumarasamy N; Shankar EM; Nandakumar S; Murugavel KG; Balakrishnan P; Solomon S; Thyagarajan SP
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):793-6. PubMed ID: 18556033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of IgM anti-HD during interferon therapy.
    Marinucci G; Hassan G; Di Giacomo C; Dato A; Barlattani A; Costa F
    Prog Clin Biol Res; 1993; 382():311-8. PubMed ID: 8502696
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term delta antigenaemia without appearance of delta antibody in two immunodeficient patients.
    Grippon P; Ribiere O; Cadranel JF; Pelletier S; Pillot B; Emerit J; Opolon P
    Lancet; 1987 May; 1(8540):1031. PubMed ID: 2883365
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serological markers for hepatitis B virus and delta antibody in Brazilian male homosexuals].
    Ferraz ML; Vilela MP; Silva AE; Paiva ER
    Rev Paul Med; 1985; 103(5):228-30. PubMed ID: 3832313
    [No Abstract]   [Full Text] [Related]  

  • 33. [Delta hepatitis].
    Rizzetto M; Verme G
    Internist (Berl); 1985 Oct; 26(10):628-32. PubMed ID: 3908367
    [No Abstract]   [Full Text] [Related]  

  • 34. Infection with delta agent in Pakistan. Introduction of a new hepatitis agent.
    Malik IA; Ahmed A; Iqbal M; Legters LJ; Luqman M; Akhtar MA
    J Pak Med Assoc; 1988 May; 38(5):126-8. PubMed ID: 3146653
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment.
    Mederacke I; Yurdaydin C; Dalekos GN; Bremer B; Erhardt A; Cakaloglu Y; Yalcin K; Gurel S; Zeuzem S; Zachou K; Bozkaya H; Dienes HP; Manns MP; Wedemeyer H;
    Antivir Ther; 2012; 17(2):305-12. PubMed ID: 22293066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delta hepatitis in Malaysia.
    Sinniah M; Dimitrakakis M; Tan DS
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of anti-hepatitis delta virus antibody in chronic liver disease in Somalia.
    Aceti A; Mohamed OM; Paparo BS; Mohamud OM; Quaranta G; Maalin KA; Sebastiani A
    Trans R Soc Trop Med Hyg; 1991; 85(4):541-2. PubMed ID: 1755067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt.
    el Zayadi A; Ponzetto A; Selim O; Forzani B; Lavarini C; Rizzetto M
    Hepatogastroenterology; 1988 Dec; 35(6):313-5. PubMed ID: 3265126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis delta virus infection: a recently imported disease in New Zealand.
    Ramirez AM; Lee SP; Woodfield DG
    N Z Med J; 1987 Apr; 100(822):235-7. PubMed ID: 3454892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies to thymic epithelial cells in HDV infection.
    Lenkei R; Norder H; Biberfeld G; Magnius LO
    Prog Clin Biol Res; 1987; 234():257-65. PubMed ID: 3306702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.